Express scripts prior authorization form 2022 pdf

Prior authorization requests for covered outpatient medications are processed through Express Scripts, Inc. (ESI). ESI is the pharmacy benefits manager for Maryland Physicians Care. Providers can access the Formulary Search Tool to find additional information about medications or call ESI directly at 1-800-753-2851. To find the appropriate Prior Auth form, look below under Prior-Authorization Forms for Outpatient Pharmacy Medications Processed Through ESI.

Express scripts prior authorization form 2022 pdf

MPC Medical Benefit Drug Prior Authorization Request Process (Buy & Bill)

Prior authorization for medications reviewed by Maryland Physicians Care must be submitted using the
Medical Benefit Drug Prior Authorization Form.

For MPC Clinical Policies click here


  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
  • Reset
  • Acute Hereditary Angioedema Products RX-PA-001
  • Adakveo RX-PA-003
  • Alpha1-Proteinase Inhibitors RX-PA-004
  • Apretude (cabotegravir) RX-PA-049
  • Botox, Dysport, Myobloc, Xeomin RX-PA-005
  • Cabenuva RX-PA-006
  • Cinryze, Haegarda RX-PA-007
  • Crysvita RX-PA-060
  • Cubicin RX-PA-045
  • Dalvance RX-PA-043
  • Empaveli RX-PA-039
  • Entyvio (vedolizumab) RX-PA-008
  • Exondys 51 and Vyondys 53 RX-PA-009
  • Gattex (Teduglutide) RX-PA-010
  • Glucocerebrosidase Replacement Enzymes (Ceremyze and VPRIV) RX-PA-011
  • GnRH Agonists & Antagonists RX-PA-012
  • Granulocyte Colony-Stimulating Factors RX-PA-013
  • High Cost Low Volume Drug Risk Mitigation Policy RX-PA-014
  • Hyaluronic Acid Derivatives RX-PA-015
  • Infliximab Products RX-PA-016
  • Intravenous Immune Globulin (IVIG) & Subcutaneous Immune Globulin (SCIG) RX-PA-017
  • Intravitreal Corticosteroid Implants RX-PA-018
  • IV and Injectable Iron Products RX-PA-044
  • Juxtapid and Evkeeza RX-PA-040
  • Kanuma (sebelipase alfa) RX-PA-019
  • Kyrstexxa (Pegloticase) RX-PA-020
  • Lemtrada (alemtuzumab) RX-PA-047
  • Mucopolysaccharidosis Agents RX-PA-021
  • Nexviazyme RX-PA-542
  • Nplate (Romiplostim) RX-PA-023
  • Nulibry® (fosdenopterin) RX-PA-041
  • Nulojix (Belatacept) RX-PA-024
  • Ocrevus RX-PA-025
  • Ocular Disorders RX-PA-026
  • Onpattro RX-PA-027
  • Osteoporosis Injectables RX-PA-028
  • Oxlumo® (lumasiran) RX-PA-042
  • Pulmonary Arterial Hypertension (PAH) Products RX-PA-029
  • Rethymic RX-PA-063
  • Revcovi RX-PA-002
  • Rituxan (rituximab) RX-PA-030
  • Signifor (Pasireotide) RX-PA-031
  • Soliris (Eculizumab) RX-PA-032
  • Specialty Drug Management RX-PA-033
  • Specialty Enzymes RX-PA-034
  • Spinraza RX-PA-035
  • Tepezza RX-PA-064
  • Tysabri (natalizumab) RX-PA-036
  • Ultomiris RX-PA-054
  • Vyepti RX-PA-046
  • Xiaflex (Collagenase Clostridium Histolyticum) MP-097
  • Xolair Immunologicals RX-PA-037
  • Zolgensma RX-PA-038

Express scripts prior authorization form 2022 pdf

Non-Formulary Exception Process

To support routine non-Formulary pharmacy authorization decisions, MPC uses guidelines based on FDA-approved indications, evidence-based clinical literature, recognized off-label use supported by peer-reviewed clinical studies, and member’s benefit design, which are applied based on individual members.

The Non-Formulary Guideline is used to evaluate authorization requests for which there are no specific guidelines. A request may be authorized if the medications are deemed to be medically necessary for any of the following reasons:

  • up to two (2) formulary drugs (when available) in the same therapeutic category have been utilized for an adequate trial and have not been effective,
  • formulary drugs in the same therapeutic category are contra-indicated, or
  • there is no therapeutic alternative listed on the Formulary.

To request a non-formulary exception, call the prior authorization team at Express Scripts, Inc. at 1-800-753-2851.

Express scripts prior authorization form 2022 pdf

Specialty Medications

Prior authorization review for specialty medications is based on the pharmacy benefit used for the distribution of the medication.

Express scripts prior authorization form 2022 pdf

Oncology Medications

Eviti will process prior Authorization for medications related to an oncology treatment regimen. Your office can sign up for training at https://connect.eviti.com to learn how to access the web-based system. If you have any additional questions, please call Eviti, Inc., our oncology vendor, at 1-888-678-0990 (toll-free).

Request for authorization for oncology medications off-label use will be processed through Maryland Physicians Care.

Express scripts prior authorization form 2022 pdf

Hepatitis C Medications

Hepatitis C drug prior authorizations are processed by MPC’s Pharmacy Department using the Maryland Department of Health (MDH) Hepatitis C clinical criteria. Fax the completed MDH Hepatitis C Prior Authorization Form with clinical information to 800-953-8856.

How do I get prior authorization for Express Scripts?

Please call us at 800.753. 2851 to submit a verbal prior authorization request if you are unable to use Electronic Prior Authorization. Prior Authorization criteria is available upon request.

Why does Express Scripts require prior authorization?

Express Scripts, the TRICARE pharmacy contractor, sometimes needs more information from your doctor about your prescription before it can be covered by your plan. Express Scripts uses this information to help control costs. They also must make sure the medication is an effective treatment.

What are three drugs that require prior authorization?

Most common prescription drugs requiring preauthorization: Androgel. Aripiprazole. Copaxone. Crestor.

How can I make my prior authorization faster?

16 Tips That Speed Up The Prior Authorization Process.
Create a master list of procedures that require authorizations..
Document denial reasons..
Sign up for payor newsletters..
Stay informed of changing industry standards..
Designate prior authorization responsibilities to the same staff member(s)..